“Sglt2 Inhibitors And The Clinical Conundrum Of Heart Failure With Preserved Ejection Fraction” (2022) Journal of Pharmaceutical Negative Results, pp. 2200–2204. doi:10.47750/pnr.2022.13.S04.273.